Comparison of graft versus host disease with three different alemtuzumab schedules in unrelated donor fludarabine and melphalan allografts

Alemtuzumab conditioning is highly effective at reducing the incidence of acute and chronic graft versus host disease (GVHD) in reduced intensity fludarabine and melphalan transplantation with ciclosporin monotherapy. Less frequent and lower dose scheduling may be used with sibling donors but an opt...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Green, Kile, Pearce, Kim, Sellar, Rob S, Jardine, Laura, Nicolson, Phillip LR, Nagra, Sandeep, Bigley, Venetia, Jackson, Graham, Dickinson, Anne M, Thomson, Kirsty, Mackinnon, Stephen, Craddock, Charles, Peggs, Karl S, Collin, Matthew
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6588535/
https://ncbi.nlm.nih.gov/pubmed/28212937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.02.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados